Diabetes

This hub delivers an in-depth, evidence-based exploration of diabetes mellitus, uniting authoritative articles on disease mechanisms, diagnosis, management, and prevention. Covering both type 1 and type 2 diabetes, as well as rare and secondary forms, this collection provides readers with comprehensive information on risk factors, clinical presentation, complications, and the latest advances in research and technology. Topics include the impact of nutrition and lifestyle, pharmacological and non-pharmacological therapies, monitoring strategies, acute and chronic complications, and innovative developments such as artificial pancreas systems and digital health tools. These resources also examine the psychosocial aspects of living with diabetes and offer practical guidance for both patients and healthcare professionals. Whether you seek foundational knowledge or current developments in diabetes care, this hub serves as a trusted, up-to-date reference.

Okra and Diabetes: What Research Says About Its Blood Sugar Control Effects

Emerging evidence from clinical and mechanistic studies reveals how okra’s natural compounds lower blood sugar, balance lipids, and support overall metabolic health in diabetes.

Supplements for Diabetes

The Risks of Prediabetes

Diabetes Pathophysiology

What is HbA1C Testing?

Diabetes and Vision

Are Low Carbohydrate Diets Good for Type 2 Diabetes?

Hypoglycemic Unawareness

Diabetes in Men versus Women

How Baking Soda Affects People with Type 2 Diabetes

Encapsulating Islet Cells for the Treatment of Diabetes

Diabetes Diagnosis

See more featured articles »

What is Diabetic Ketoacidosis?

Diabetes Symptoms

Diabetes and Pregnancy

Epigenetic Mechanisms in Type 2 Diabetes

Nonketotic Hyperosmolar Coma

Does the Keto Diet Increase the Risk of Diabetes?

Diabetic Nephropathy Symptoms

Diabetic Mastopathy: Complication of Diabetes Mellitus

Diabetic Retinopathy Symptoms

Red Blood Cell Morphology Changes in Diabetes

Genetic Testing for Diabetes

What is a Diabetic Coma?

Diabetic Retinopathy Treatments

Diabetic Neuropathy Treatments

Diabetic Retinopathy Diagnosis

History of Diabetes

Is a Plant-Based Diet Good for Type 2 Diabetes?

What's Next for Semaglutide? Beyond Diabetes and Weight Loss

Bionic Advancements: The Next Generation of Insulin Delivery Devices

Adiponectin and Diabetes

Diabetic Nephropathy Treatment

Artificial Pancreas Systems: The Future of Diabetes Management?

Cause of Diabetic Coma

How Does Semaglutide Work to Lose Weight?

Animals That Can Detect Hypoglycemia

Advanced Diabetic Ketoacidosis

Diabetes and Skin Problems

Diabetic Neuropathy Pathogenesis

Walking After Meals: Small Habit, Big Metabolic Gains

Diabetes Management

Research into a Cure for Diabetes

How does Gestational Diabetes Affect the Baby?

Treatment and Prognosis for Diabetic Mastopathy

Risks to Infants of Diabetic Mothers

Harnessing the Power of AI: Predicting Diabetes Onset Before It Strikes

Can I reverse my prediabetes naturally

The Impact of Glucagon on Diabetes Management

Diabetic Retinopathy Risk Factors

Diabetes Complications

Diabetes in Men

What is Diabetic Retinopathy?

Diabetic Hypoglycemia Treatments

Diabetes Types

What is Diabetic Nephropathy?

What is HbA1c?

Diabetes and Wound Healing

Causes of Foot Pain

Understanding MODY 5: A Rare Genetic Form of Diabetes

Diabetes Risk Factors

Diabetic Foot Problems

Does the 'Stomach Flu' Vaccine Prevent Type I Diabetes?

Pins and Needles and Diabetes

Diabetic Mastopathy Diagnosis

What Causes Diabetes?

COVID-19 and Diabetes

Low Sugar Foods for Diabetes

Diabetic Neuropathy Symptoms

What is Diabetic Neuropathy?

Diabetes and Periodontitis

Diabetic Neuropathy Diagnosis

Diabetes Screening

Vitamin D and Type 2 Diabetes

Navigating Insulin Pumps: Technology, Benefits, and What’s Next

Diabetic Coma Treatments

Diabetic Ketoacidosis Causes

Effects of Hyperglycemia on the Vascular System

Diabetes and Sleep

The Future of Diabetes Treatment

What is Diabetic Hypoglycemia?

Diabetic Emergencies: What to Do

What Causes Diabetic Nephropathy (Kidney Disease)?

What is Diabetes?

Semaglutide and Type 2 Diabetes: Efficacy, Safety, and Outcomes

Diabetic Coma Severe Hypoglycemia

Alcohol and Diabetes

Diabetic Hypoglycemia Etiology

What are Nightmares and Why Do They Occur?

Diabetes and Mucormycosis

Latest Diabetes News and Research

Palmatine improved fatty liver markers in a preclinical type 2 diabetes study

Researchers used a bioinformatics-plus-rat-model approach to investigate how palmatine may help treat T2DM-associated MASLD, identifying five core targets: ADRB2, BCL3, EGR1, FOS, and MAP3K8. In rats, palmatine improved liver injury, inflammation, oxidative stress, glycolipid metabolism, steatosis, and fibrosis, while reducing apoptosis-related signaling, providing a preclinical foundation for further therapeutic study.

23 Mar 2026

Mediterranean diet may protect health through mitochondrial microproteins

A new study led by researchers at the USC Leonard Davis School of Gerontology suggests that the benefits of the Mediterranean diet may be driven, in part, by tiny proteins hidden within our mitochondria, opening a new window into how diet shapes aging and disease risk.

23 Mar 2026

New cholesterol guidelines emphasize earlier risk assessment and prevention

New national guidance for managing cholesterol and other blood lipids emphasizes earlier risk assessment, more personalized treatment, and long-term prevention—including, in some cases, treatment beginning as early as age 30.

23 Mar 2026

Early obesity treatment reduces long-term health risks for all children

Children living with obesity but showing no signs of metabolic complications still have a significantly increased risk of developing type 2 diabetes, high blood pressure, and abnormal blood lipid levels later in life.

23 Mar 2026

Firmer potatoes lower post-meal blood sugar spikes

Minimally cooked potatoes may reduce blood sugar spikes, but benefits are short-lived and specific to certain populations, as shown in recent research.

23 Mar 2026

Researchers explore "block and lock" strategy for functional HIV cure

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs-commonly referred to as antiretroviral therapy-the virus usually rushes back within weeks.

23 Mar 2026

New NYU study identifies lower heat risk thresholds for vulnerable older adults

Nationally, heat-related mortality has risen by nearly 17 % per year since 2016. As a result, New York City now issues heat alerts and opens cooling centers when the heat index is forecast to reach 95 degrees Fahrenheit or higher for at least two consecutive days or a heat index of 100 degrees Fahrenheit or higher for any length of time.

23 Mar 2026

Replacing sedentary time improves insulin resistance in adolescents

Adolescents who replaced just half an hour of sedentary behaviors, such as sitting on the couch or spending time at the computer, each day for moderate-to-vigorous physical activity or sleep may lower their insulin resistance, a key factor in preventing the development of Type 2 diabetes, according to preliminary research presented at the American Heart Association's EPI|Lifestyle Scientific Sessions 2026.

23 Mar 2026

Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trials

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in people with early symptomatic, amyloid-positive Alzheimer’s disease. Semaglutide was generally consistent with its known safety profile and showed some biomarker changes, but these did not translate into clinical benefit.

22 Mar 2026

GLP-1 drugs cut heart and kidney risks in type 1 diabetes study

In a large target trial emulation of 174,678 people with type 1 diabetes, GLP-1 receptor agonist initiation was associated with lower risks of major cardiovascular events and end-stage kidney disease over five years. The study also found no increased risk of hospitalization for diabetic ketoacidosis or severe hypoglycemia, supporting further randomized trials of GLP-1RAs as adjunctive therapy in type 1 diabetes.

22 Mar 2026

Losing health insurance worsens diabetes outcomes in low-income adults

Losing health insurance can quickly worsen health for people with diabetes as patients struggle to control the disease after coverage is interrupted, according to new research from Oregon Health & Science University,

22 Mar 2026

AI diet plans underestimate teen nutrition and miss key nutrients

AI tools for adolescent diet planning may fall short, consistently underestimating nutrient intake and energy needs compared to individualized dietitian plans.

20 Mar 2026

Study links gut microbiome imbalance to worsening kidney disease

Researchers at UC Davis School of Medicine have uncovered how an imbalanced gut microbiome escalates the production of metabolic byproducts by certain gut bacteria.

19 Mar 2026

Mandated caps reduce insulin out-of-pocket costs among US Medicare beneficiaries

A new analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health finds that out-of-pockets caps on insulin for Medicare Part D beneficiaries have reined in insulin prices.

19 Mar 2026

Study identifies protein biomarker and potential treatment for schizophrenia

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction.

19 Mar 2026

Urban living may reduce risk of first-time stroke

While urban life is often associated with stress and pollution, living in more intensely developed neighborhoods may actually protect against stroke, a new University of Michigan study suggests.

19 Mar 2026

Hydration programs found insufficient to reduce kidney stone recurrence

Kidney stones can cause some of the most intense pain people ever experience, affecting daily life and leading many to hospital emergency visits.

19 Mar 2026

How long should you take GLP-1 drugs? Study links longer use to lower heart risk

Continuous use of GLP-1 receptor agonists in adults with type 2 diabetes was associated with a lower risk of major cardiovascular events compared with sulfonylureas, with benefits increasing over time. Discontinuation or interruption was associated with a progressive loss of this protective effect, with risks approaching those of comparator therapy.

19 Mar 2026

Weaning reshapes gut microbes to strengthen lifelong immune defenses

According to a team of researchers at Baylor College of Medicine, Tongji University and collaborating institutions, weaning or switching from milk to solid food in early life doesn't just change what babies eat, it helps reprogram the gut's immune defenses to mount faster and stronger responses that can last into adulthood.

19 Mar 2026

Early morning workouts may improve cardiometabolic health

People who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.26).

19 Mar 2026